Lonza Group Ag
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug…
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2023-12-21 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-12-05 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-07-10 | Daniel S. Goldman · D-NY | House | Sold | $15,001 - $50,000 |
| 2021-04-13 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2021-02-17 | Peter Meijer · R-MI | House | Sold | $15,001 - $50,000 |
| 2021-01-28 | Peter Meijer · R-MI | House | Sold | $1,001 - $15,000 |
| 2020-01-13 | Greg Gianforte · R-MT | House | Bought | $15,001 - $50,000 |
| 2019-06-24 | Donna E. Shalala · D-FL | House | Sold | $1,001 - $15,000 |
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.